http://www.fpnotebook.com/
Human Granulocytic Anaplasmosis
Aka: Human Granulocytic Anaplasmosis, HGA, Anaplasma phagocytophila, Human Granulocytic Ehrlichiosis, Ehrlichia equi, Ehrlichia phagocytophila, Ehrlichiosis, Human anaplasmosis, Human ehrlichiosis
- See also
- Human Monocytic Ehrlichiosis
- Vector Borne Disease
- Prevention of Tick-borne Infection
- Tick Removal
- Pathophysiology
- Transmission: Tick bite
- Small gram-negative organisms
- Pleomorphic
- Obligate intracellular organisms
- Disease: Human Granulocytic Anaplasmosis (HGA)
- Previously known as: Human Granulocytic Ehrlichiosis
- Causative Organism
- New Name: Anaplasma phagocytophila
- Prior Name: Ehrilichia phagocytophila, E. equi
- Epidemiology
- Majority of cases occur April to September
- Tick Carriers
- Deer Tick (Ixodes Scapularis)
- Dog tick (Dermacentor variabilis)
- United States endemic areas
- Minnesota
- Wyoming
- New York
- Symptoms (Occur 7-10 days after tick bite)
- Common Initial Symptoms
- Fever
- Shaking chills
- Myalgia
- Headache
- Other symptoms
- Nausea and Vomiting
- Abdominal Pain
- Diarrhea
- Cough
- Confusion
- Signs: Rash (occurs in <10% of patients)
- Involves trunk
- Spares hands and feet
- Not associated with tick bite site
- Labs
- Complete Blood Count
- Leukopenia
- Thrombocytopenia (unique to anaplasmosis compared with Babesia and Lymes Disease)
- Mild transient Anemia
- Liver transaminases increased
- Aspartate Aminotransferase (AST) increased
- Alanine Aminotransferase (ALT) increased
- Ehrlichiosis Serology
- Positive two weeks after onset
- Used for confirmation, not for diagnosis
- Other variably present laboratory findings
- Increased Erythrocyte Sedimentation Rate (ESR)
- Increased Blood Urea Nitrogen (BUN)
- Increased Serum Creatinine
- Management: Antibiotics for two weeks
- Doxycycline or
- Chloramphenicol or
- Rifampin
- Prevention
- See Prevention of Vector-borne Infection
- References
- (1995) MMWR Morb Mortal Wkly Rep 44:593-5
- Fritz (1998) Infect Dis Clin North Am 12:123-36
- Glushko (1997) Postgrad Med 101(6):225-30
- McQuiston (1999) Emerg Infect Dis 5:635-42
- Weinstein (1996) Am Fam Physician 54(6):1971-6